Forcefield Therapeutics
unknown
unknown
Stage
1
Investors
About
Forcefield Therapeutics develops biologic therapeutics aimed at protecting heart function by preventing or arresting the loss of cardiomyocytes that occurs following myocardial infarction, with the goal of reducing progression to heart failure.
Explore Forcefield Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.